4 models fit Barry Callebaut AG and they disagree: 1 of 4 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Bronze44
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionBarry Callebaut AG (BARN.SW)
Fair value (4 models)
CHF 762
ACCE price target
CHF 1128
Rating
Overvalued
Horizon
12 months
Fair value published on 22 Oct 2026, 12:04 CEST.
ACCE price target published on 22 Oct 2026, 16:00 CEST.
Rating published on 22 Oct 2026, 12:04 CEST.
Price used: CHF 1155 at the close on 23 Oct 2026, 17:30 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
51.5% above
-34.0% to fair value
ACCE score
44
out of 100
P/E
26.1x
forward 21.8x
1-year return
-3.3%
Dividend yield
2.48%
Barry Callebaut AG in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Barry Callebaut makes cocoa and chocolate ingredients (cocoa liquor, butter and powder, plus compound coatings and fillings) that it sells mostly on a business-to-business basis to food and confectionery manufacturers, and it is the world's largest cocoa processor by volume. The moat is scale and integration: its grinding footprint and the long supplier relationships that sit behind it are hard to replicate, and that position matters more when cocoa supply is tight. Revenue fell 7.3% in the most recent year, so the near-term case rests on whether the cocoa price cycle turns and on operating leverage returning as volumes recover. Shares trade on a trailing P/E of 26.5 and a forward P/E of 22.1, which implies the market expects earnings to rebuild, but a 4.6% operating margin and 9.4% ROE leave little room for another year of volume decline. This is a name worth a deeper look to test whether the margin recovery is already visible in the order book.